Pembrolizumab, Nc410
Cervical Cancer, Ovarian Cancer, Advanced Or Metastatic Solid Tumors, Lung Cancer, Gastric Cancer, Endometrial Cancer, Esophageal Cancer, Head Neck Cancer, Colo-Rectal Cancer, Microsatellite Instability Low, Microsatellite Instability High, Microsatellite Stable
Active Not Recruiting
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors
―